• Alexandra Costachi
  • Catalina Elena Cioc
  • Alice Buteica
  • Oana Stefana Popescu
  • Anica Dricu



nanoparticles, glioblastoma, iron oxide


Nanotechnology offers a new horizon for cancer drug administration and systemic safety of oncological treatments. Compared with conventional pharmaceutical forms, nanoparticles (NPs) have many advantages such as larger surface, ability to adsorb and targeted delivery of different types of drugs, providing decreased side effects and a patient customed approach in cancer treatment. Due to their diverse chemical composition, NPs offer the possibility of developing innovative therapies, which may be also applied in glioblastoma treatment. Fe3O4 magnetic nanoparticles (MNPs) have been previously used in cancer treatment, as targeted drug delivery systems. Helianthin is an azo dye compound that we found to induce cell death in high grade glioma (HGG) cells. In this study, we analyzed the in vitro effect of MNPs loaded with Helianthin (HeMNPs) on a glioblastoma cell line (GB2B).


Játiva P, Ceña V. Use of nanoparticles for glioblastoma treatment: a new approach. Nanomedicine. 2017;12(20):2533-54.

Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med. 2005;352(10):997-1003.

Harder BG, Blomquist MR, Wang J, Kim AJ, Woodworth GF, Winkles JA, et al. Developments in blood-brain barrier penetrance and drug repurposing for improved treatment of glioblastoma. Frontiers in oncology. 2018;8:462.

Jennings MT, Frenchman M, Shehab T, Johnson MD, Creasy J, LaPorte K, et al. Gliomatosis cerebri presenting as intractable epilepsy during early childhood. Journal of Child Neurology. 1995;10(1):37-45.

Miranda A, Blanco-Prieto M, Sousa J, Pais A, Vitorino C. Breaching barriers in glioblastoma. Part I: molecular pathways and novel treatment approaches. International journal of pharmaceutics. 2017;531(1):372-88.

Thomas AA, Brennan CW, DeAngelis LM, Omuro AM. Emerging therapies for glioblastoma. JAMA neurology. 2014;71(11):1437-44.

De Jong WH, Borm PJ. Drug delivery and nanoparticles: applications and hazards. International journal of nanomedicine. 2008;3(2):133.

Massart R. Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE transactions on magnetics. 1981;17(2):1247-8.

Ardelean IL, Stoencea LBN, Ficai D, Ficai A, Trusca R, Vasile BS, et al. Development of stabilized magnetite nanoparticles for medical applications. Journal of Nanomaterials. 2017;2017.

Fudulu A, Purcareanu B, Olariu L, Meghea A, Radu M, Stan L, et al. Antiproliferative effect of Fe3O4/methotrexate nanoparticles on metastatic prostate carcinoma cells DU145. University Politehnica of Bucharest scientific bulletin series B-chemistry and materials science. 2018;80(3):3-12.

Mîndril? I, Buteic? S, Mihaiescu D, Badea G, Fudulu A, M?rg?ritescu D. Fe3O4/salicylic acid nanoparticles versatility in magnetic mediated vascular nanoblockage. Journal of Nanoparticle Research. 2016;18(1):10.

Farr-Jones MA, Parney IF, Petruk KC. Improved technique for establishing short term human brain tumor cultures. Journal of neuro-oncology. 1999;43(1):1-10.

Wang S, Zhao X, Wang S, Qian J, He S. Biologically inspired polydopamine capped gold nanorods for drug delivery and light-mediated cancer therapy. ACS applied materials & interfaces. 2016;8(37):24368-84.

Sevastre A-S, Horescu C, Carina Baloi S, Cioc CE, Vatu BI, Tuta C, et al. Benefits of nanomedicine for therapeutic intervention in malignant diseases. Coatings. 2019;9(10):628.

Oprita A, Sevastre A-S. New pharmaceutical dosage forms used in the treatment of breast cancer. Polymeric micelles. Medico Oncology. 2020;1(1):38-52.

Saha A, Mohanta SC, Deka K, Deb P, Devi PS. Surface-engineered multifunctional Eu: Gd2O3 nanoplates for targeted and pH-responsive drug delivery and imaging applications. ACS applied materials & interfaces. 2017;9(4):4126-41.

Pourgholi F, Farhad J-N, Kafil HS, Yousefi M. Nanoparticles: Novel vehicles in treatment of Glioblastoma. Biomedicine & Pharmacotherapy. 2016;77:98-107.

Vinardell MP, Mitjans M. Antitumor activities of metal oxide nanoparticles. Nanomaterials. 2015;5(2):1004-21.

Shahabadi N, Jamshidbeigi M, Falsafi M. Functionalization of Fe3O4@ SiO2 magnetic nanoparticles with nicotinamide and in vitro DNA interaction. Journal of Molecular Liquids. 2016;224:227-33.